Cannabis industry data insights provided by BDS Analytics reveals that February medical marijuana sales in Arizona increased by 39% compared to February 2019.
The report discloses category-specific Arizona medical marijuana industry sales data, as NCV Newswire reported:
In February 2020, cannabis sales in Arizona’s medical dispensaries were $69.5 million, a two percent decline from January. Compared to the previous February, sales in Arizona grew by over 37 percent. Year-to-date through February, sales have reached $140.3 million, a $39.2 million increase from the same period last year, representing 39 percent growth.
Flower sales accounted for nearly 49 percent of overall revenue for the month with $33.8 million in sales. Pre-rolled Joints, which are tracked as a separate category, accounted for nearly four percent of revenue with $2.5 million in sales. Compared to the previous February, sales of both Flower and Pre-rolled Joints increased by 47 percent.
Concentrate sales accounted for more than 35 percent of overall revenues with sales totaling $24.4 million in February. Vape products, the largest segment of the Concentrates category, generated $16 million in sales, accounting for 66 percent of the Arizona Concentrates market and 23 percent of sales across all categories. Compared to February 2019, sales of Dabbable Concentrates grew by 36 percent, while Vape sales grew by 33 percent.
The Ingestibles category accounted for 11 percent of sales in February with $7.7 million in revenue. In February, the $7 million in sales from Edibles (a sub-category within Ingestibles) generated nearly 91 percent of Ingestibles sales overall, while Sublinguals made up the remaining nine percent. Compared to the previous February, Edibles sales increased by 27 percent and Sublingual sales decreased 27 percent.
View dispensaries in Arizona.